Venous Malformations Sclerotherapy: Outcomes, Patient Satisfaction and Predictors of Treatment Success

[1]  J. Reekers,et al.  Patient-Reported Outcomes of Bleomycin Sclerotherapy for Low-Flow Vascular Malformations and Predictors of Improvement , 2018, CardioVascular and Interventional Radiology.

[2]  J. Keller,et al.  Outcome Measures After Sclerotherapy of Venous Malformations: A Systematic Review , 2018, CardioVascular and Interventional Radiology.

[3]  A. Mansilha,et al.  Vascular malformations: classification, diagnosis and treatment. , 2018, International angiology : a journal of the International Union of Angiology.

[4]  M. Wildgruber,et al.  Vascular Anomalies (Part II): Interventional Therapy of Peripheral Vascular Malformations , 2018, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[5]  S. Mitchell,et al.  Outcomes of Venous Malformation Sclerotherapy: A Review of Study Methodology and Long-Term Results , 2017, Seminars in Interventional Radiology.

[6]  P. Pereira,et al.  Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System , 2017, CardioVascular and Interventional Radiology.

[7]  N. Tomiyama,et al.  Cost-Effectiveness Analysis of Percutaneous Sclerotherapy for Venous Malformations. , 2016, Journal of vascular and interventional radiology : JVIR.

[8]  A. Rothova,et al.  Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents. , 2016, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[9]  Young Wook Kim,et al.  Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations , 2016, European Radiology.

[10]  N. Tomiyama,et al.  Percutaneous sclerotherapy for venous malformations in the extremities: clinical outcomes and predictors of patient satisfaction , 2014, SpringerPlus.

[11]  M. Rovers,et al.  Effectiveness of Sclerotherapy, Surgery, and Laser Therapy in Patients With Venous Malformations: A Systematic Review , 2013, CardioVascular and Interventional Radiology.

[12]  Yunbo Jin,et al.  Outcomes and Complications of Sclerotherapy for Venous Malformations , 2013, Vascular and endovascular surgery.

[13]  G. Legiehn,et al.  A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations , 2010, Seminars in interventional radiology.

[14]  I. McCafferty,et al.  Venous malformations of the limbs: the Birmingham experience, comparisons and classification in children. , 2010, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[15]  Yunbo Jin,et al.  Craniofacial venous malformations: magnetic resonance imaging features that predict treatment outcome. , 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[16]  K. Park,et al.  Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. , 2009, Journal of vascular surgery.

[17]  W. Hop,et al.  Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformations. , 2009, Radiology.

[18]  S. Kanazawa,et al.  Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief , 2009, European Radiology.

[19]  G. Legiehn,et al.  Venous malformations: classification, development, diagnosis, and interventional radiologic management. , 2008, Radiologic clinics of North America.

[20]  F. Brunelle,et al.  Classification of venous malformations in children and implications for sclerotherapy , 2003, Pediatric Radiology.

[21]  P. Causer,et al.  Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. , 2002, Radiology.

[22]  J. Mulliken,et al.  Sclerotherapy of craniofacial venous malformations: complications and results. , 1999, Plastic and reconstructive surgery.

[23]  D. Green Mechanism of action of sclerotherapy. , 1993, Seminars in dermatology.